Phenotypic heterogeneity and disease course in three murine strains with mutations in genes encoding for α1 and β glycine receptor subunits
Identifieur interne : 008315 ( Main/Merge ); précédent : 008314; suivant : 008316Phenotypic heterogeneity and disease course in three murine strains with mutations in genes encoding for α1 and β glycine receptor subunits
Auteurs : Simon [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 1997-03.
English descriptors
- KwdEn :
- Animals, Chloride channel, Chromosome Aberrations (genetics), Chromosome Disorders, DNA Mutational Analysis, Female, Genes, Recessive (genetics), Glycine, Heterozygote Detection, Humans, Hyperekplexia, Male, Mice, Mice, Neurologic Mutants, Motor Activity (physiology), Myoclonus, Phenotype, Receptors, Glycine (genetics), Receptors, Glycine (physiology), Spasticity, Species Specificity, Spinal Cord (physiopathology), Spinal cord.
- MESH :
- chemical , genetics : Receptors, Glycine.
- genetics : Chromosome Aberrations, Genes, Recessive.
- physiology : Motor Activity, Receptors, Glycine.
- physiopathology : Spinal Cord.
- Animals, Chromosome Disorders, DNA Mutational Analysis, Female, Heterozygote Detection, Humans, Male, Mice, Mice, Neurologic Mutants, Phenotype, Species Specificity.
Abstract
Impaired glycinergic inhibition causes human hyperekplexia, and may be involved in the pathogenesis of movement disorders associated with uremia, spinal cord lesions, DDT poisoning, and tetanus. Three autosomal recessive mutant mouse strains with single‐gene mutations affecting either the α1 (spasmodic and oscillator) or β (spastic) subunits of the glycine receptor were studied. Serial videotaped examinations assessed the severity of hyperkinetic features. Homozygote oscillator mice appeared normal until postnatal day (P) 11–14, when decreased exploratory movements, spastic gait, stimulus‐induced myoclonic bouts, rigidity, and tremor were noticeable. All symptoms gradually worsened until death by P21–P23. In contrast, spastic and spasmodic mice were most severely affected by the 3rd–5th week of life and had a lessening of symptom severity in adulthood. Within each mutant strain, there was marked interanimal variation of severity of the other motor abnormalities, possibly because of stochastic variability in developmental processes. These mutants represent good animal models for elucidation of molecular and cellular issues regarding the glycine receptor and for the study of pathogenetic mechanisms of movement disorders.
Url:
DOI: 10.1002/mds.870120213
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001741
- to stream Istex, to step Curation: 001741
- to stream Istex, to step Checkpoint: 003910
- to stream PubMed, to step Corpus: 004703
- to stream PubMed, to step Curation: 004703
- to stream PubMed, to step Checkpoint: 004601
- to stream Ncbi, to step Merge: 004C79
- to stream Ncbi, to step Curation: 004C79
- to stream Ncbi, to step Checkpoint: 004C79
Links to Exploration step
ISTEX:7D69BAD3DFD4B4FA6A4FC035DEC3F9760664B745Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Phenotypic heterogeneity and disease course in three murine strains with mutations in genes encoding for α1 and β glycine receptor subunits</title>
<author><name sortKey="Simon" sort="Simon" uniqKey="Simon" last="Simon">Simon</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:7D69BAD3DFD4B4FA6A4FC035DEC3F9760664B745</idno>
<date when="1997" year="1997">1997</date>
<idno type="doi">10.1002/mds.870120213</idno>
<idno type="url">https://api.istex.fr/document/7D69BAD3DFD4B4FA6A4FC035DEC3F9760664B745/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001741</idno>
<idno type="wicri:Area/Istex/Curation">001741</idno>
<idno type="wicri:Area/Istex/Checkpoint">003910</idno>
<idno type="wicri:doubleKey">0885-3185:1997:Simon:phenotypic:heterogeneity:and</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:9087981</idno>
<idno type="wicri:Area/PubMed/Corpus">004703</idno>
<idno type="wicri:Area/PubMed/Curation">004703</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004601</idno>
<idno type="wicri:Area/Ncbi/Merge">004C79</idno>
<idno type="wicri:Area/Ncbi/Curation">004C79</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004C79</idno>
<idno type="wicri:doubleKey">0885-3185:1997:Simon E:phenotypic:heterogeneity:and</idno>
<idno type="wicri:Area/Main/Merge">008315</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Phenotypic heterogeneity and disease course in three murine strains with mutations in genes encoding for α1 and β glycine receptor subunits</title>
<author><name sortKey="Simon" sort="Simon" uniqKey="Simon" last="Simon">Simon</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Laboratory of Neural Control, National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, Maryland</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1997-03">1997-03</date>
<biblScope unit="vol">12</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="221">221</biblScope>
<biblScope unit="page" to="228">228</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">7D69BAD3DFD4B4FA6A4FC035DEC3F9760664B745</idno>
<idno type="DOI">10.1002/mds.870120213</idno>
<idno type="ArticleID">MDS870120213</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Chloride channel</term>
<term>Chromosome Aberrations (genetics)</term>
<term>Chromosome Disorders</term>
<term>DNA Mutational Analysis</term>
<term>Female</term>
<term>Genes, Recessive (genetics)</term>
<term>Glycine</term>
<term>Heterozygote Detection</term>
<term>Humans</term>
<term>Hyperekplexia</term>
<term>Male</term>
<term>Mice</term>
<term>Mice, Neurologic Mutants</term>
<term>Motor Activity (physiology)</term>
<term>Myoclonus</term>
<term>Phenotype</term>
<term>Receptors, Glycine (genetics)</term>
<term>Receptors, Glycine (physiology)</term>
<term>Spasticity</term>
<term>Species Specificity</term>
<term>Spinal Cord (physiopathology)</term>
<term>Spinal cord</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Receptors, Glycine</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Chromosome Aberrations</term>
<term>Genes, Recessive</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Motor Activity</term>
<term>Receptors, Glycine</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Spinal Cord</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Chromosome Disorders</term>
<term>DNA Mutational Analysis</term>
<term>Female</term>
<term>Heterozygote Detection</term>
<term>Humans</term>
<term>Male</term>
<term>Mice</term>
<term>Mice, Neurologic Mutants</term>
<term>Phenotype</term>
<term>Species Specificity</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Impaired glycinergic inhibition causes human hyperekplexia, and may be involved in the pathogenesis of movement disorders associated with uremia, spinal cord lesions, DDT poisoning, and tetanus. Three autosomal recessive mutant mouse strains with single‐gene mutations affecting either the α1 (spasmodic and oscillator) or β (spastic) subunits of the glycine receptor were studied. Serial videotaped examinations assessed the severity of hyperkinetic features. Homozygote oscillator mice appeared normal until postnatal day (P) 11–14, when decreased exploratory movements, spastic gait, stimulus‐induced myoclonic bouts, rigidity, and tremor were noticeable. All symptoms gradually worsened until death by P21–P23. In contrast, spastic and spasmodic mice were most severely affected by the 3rd–5th week of life and had a lessening of symptom severity in adulthood. Within each mutant strain, there was marked interanimal variation of severity of the other motor abnormalities, possibly because of stochastic variability in developmental processes. These mutants represent good animal models for elucidation of molecular and cellular issues regarding the glycine receptor and for the study of pathogenetic mechanisms of movement disorders.</div>
</front>
</TEI>
<double doi="10.1002/mds.870120213"><ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Phenotypic heterogeneity and disease course in three murine strains with mutations in genes encoding for α1 and β glycine receptor subunits</title>
<author><name sortKey="Simon" sort="Simon" uniqKey="Simon" last="Simon">Simon</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:7D69BAD3DFD4B4FA6A4FC035DEC3F9760664B745</idno>
<date when="1997" year="1997">1997</date>
<idno type="doi">10.1002/mds.870120213</idno>
<idno type="url">https://api.istex.fr/document/7D69BAD3DFD4B4FA6A4FC035DEC3F9760664B745/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001741</idno>
<idno type="wicri:Area/Istex/Curation">001741</idno>
<idno type="wicri:Area/Istex/Checkpoint">003910</idno>
<idno type="wicri:doubleKey">0885-3185:1997:Simon:phenotypic:heterogeneity:and</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Phenotypic heterogeneity and disease course in three murine strains with mutations in genes encoding for α1 and β glycine receptor subunits</title>
<author><name sortKey="Simon" sort="Simon" uniqKey="Simon" last="Simon">Simon</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Laboratory of Neural Control, National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, Maryland</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1997-03">1997-03</date>
<biblScope unit="vol">12</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="221">221</biblScope>
<biblScope unit="page" to="228">228</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">7D69BAD3DFD4B4FA6A4FC035DEC3F9760664B745</idno>
<idno type="DOI">10.1002/mds.870120213</idno>
<idno type="ArticleID">MDS870120213</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Chloride channel</term>
<term>Glycine</term>
<term>Hyperekplexia</term>
<term>Myoclonus</term>
<term>Spasticity</term>
<term>Spinal cord</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Impaired glycinergic inhibition causes human hyperekplexia, and may be involved in the pathogenesis of movement disorders associated with uremia, spinal cord lesions, DDT poisoning, and tetanus. Three autosomal recessive mutant mouse strains with single‐gene mutations affecting either the α1 (spasmodic and oscillator) or β (spastic) subunits of the glycine receptor were studied. Serial videotaped examinations assessed the severity of hyperkinetic features. Homozygote oscillator mice appeared normal until postnatal day (P) 11–14, when decreased exploratory movements, spastic gait, stimulus‐induced myoclonic bouts, rigidity, and tremor were noticeable. All symptoms gradually worsened until death by P21–P23. In contrast, spastic and spasmodic mice were most severely affected by the 3rd–5th week of life and had a lessening of symptom severity in adulthood. Within each mutant strain, there was marked interanimal variation of severity of the other motor abnormalities, possibly because of stochastic variability in developmental processes. These mutants represent good animal models for elucidation of molecular and cellular issues regarding the glycine receptor and for the study of pathogenetic mechanisms of movement disorders.</div>
</front>
</TEI>
</ISTEX>
<PubMed><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Phenotypic heterogeneity and disease course in three murine strains with mutations in genes encoding for alpha 1 and beta glycine receptor subunits.</title>
<author><name sortKey="Simon, E S" sort="Simon, E S" uniqKey="Simon E" first="E S" last="Simon">E S Simon</name>
<affiliation wicri:level="2"><nlm:affiliation>Laboratory of Neural Control, National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, Maryland, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Laboratory of Neural Control, National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, Maryland</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1997">1997</date>
<idno type="RBID">pubmed:9087981</idno>
<idno type="pmid">9087981</idno>
<idno type="doi">10.1002/mds.870120213</idno>
<idno type="wicri:Area/PubMed/Corpus">004703</idno>
<idno type="wicri:Area/PubMed/Curation">004703</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004601</idno>
<idno type="wicri:Area/Ncbi/Merge">004C79</idno>
<idno type="wicri:Area/Ncbi/Curation">004C79</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004C79</idno>
<idno type="wicri:doubleKey">0885-3185:1997:Simon E:phenotypic:heterogeneity:and</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Phenotypic heterogeneity and disease course in three murine strains with mutations in genes encoding for alpha 1 and beta glycine receptor subunits.</title>
<author><name sortKey="Simon, E S" sort="Simon, E S" uniqKey="Simon E" first="E S" last="Simon">E S Simon</name>
<affiliation wicri:level="2"><nlm:affiliation>Laboratory of Neural Control, National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, Maryland, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Laboratory of Neural Control, National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, Maryland</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1997" type="published">1997</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Chromosome Aberrations (genetics)</term>
<term>Chromosome Disorders</term>
<term>DNA Mutational Analysis</term>
<term>Female</term>
<term>Genes, Recessive (genetics)</term>
<term>Heterozygote Detection</term>
<term>Humans</term>
<term>Male</term>
<term>Mice</term>
<term>Mice, Neurologic Mutants</term>
<term>Motor Activity (physiology)</term>
<term>Phenotype</term>
<term>Receptors, Glycine (genetics)</term>
<term>Receptors, Glycine (physiology)</term>
<term>Species Specificity</term>
<term>Spinal Cord (physiopathology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Receptors, Glycine</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Chromosome Aberrations</term>
<term>Genes, Recessive</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Motor Activity</term>
<term>Receptors, Glycine</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Spinal Cord</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Chromosome Disorders</term>
<term>DNA Mutational Analysis</term>
<term>Female</term>
<term>Heterozygote Detection</term>
<term>Humans</term>
<term>Male</term>
<term>Mice</term>
<term>Mice, Neurologic Mutants</term>
<term>Phenotype</term>
<term>Species Specificity</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Impaired glycinergic inhibition causes human hyperekplexia, and may be involved in the pathogenesis of movement disorders associated with uremia, spinal cord lesions, DDT poisoning, and tetanus. Three autosomal recessive mutant mouse strains with single-gene mutations affecting either the alpha 1 (spasmodic and oscillator) or beta (spastic) subunits of the glycine receptor were studied. Serial videotaped examinations assessed the severity of hyperkinetic features. Homozygote oscillator mice appeared normal until postnatal day (P) 11-14, when decreased exploratory movements, spastic gait, stimulus-induced myoclonic bouts, rigidity, and tremor were noticeable. All symptoms gradually worsened until death by P21-P23. In contrast, spastic and spasmodic mice were most severely affected by the 3rd-5th week of life and had a lessening of symptom severity in adulthood. Within each mutant strain, there was marked interanimal variation of severity of the other motor abnormalities, possibly because of stochastic variability in developmental processes. These mutants represent good animal models for elucidation of molecular and cellular issues regarding the glycine receptor and for the study of pathogenetic mechanisms of movement disorders.</div>
</front>
</TEI>
</PubMed>
</double>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 008315 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 008315 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Merge |type= RBID |clé= ISTEX:7D69BAD3DFD4B4FA6A4FC035DEC3F9760664B745 |texte= Phenotypic heterogeneity and disease course in three murine strains with mutations in genes encoding for α1 and β glycine receptor subunits }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |